Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry 2001-2004, Clinical Journal of the American Society of Nephrology, vol.3, issue.6, pp.1726-1758, 2001. ,
DOI : 10.2215/CJN.01240308
Current Management of Vascular Access, Clinical Journal of the American Society of Nephrology, vol.2, issue.4, pp.786-800, 2007. ,
DOI : 10.2215/CJN.00860207
Maturation and Failure Rates in a Large Series of Arteriovenous Dialysis Access Fistulas, Vascular and Endovascular Surgery, vol.5, issue.5, pp.449-53, 2004. ,
DOI : 10.1016/S0895-7061(02)02261-6
Thrombosis in End-Stage Renal Disease, Seminars in Dialysis, vol.114, issue.3, pp.245-56, 2003. ,
DOI : 10.1093/ndt/13.3.679
Uremic bleeding: closing the circle after 30 years of controversies?, Blood, vol.94, pp.2569-74, 1999. ,
HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End-Stage Renal Disease, Seminars in Dialysis, vol.2, issue.suppl 41, pp.317-339, 2006. ,
DOI : 10.1093/clinids/4.Supplement_3.S546
Haemodialysis and platelet activation, Nephrol Dial Transplant, vol.6, issue.2, pp.40-42, 1991. ,
Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis, International Journal of Clinical Practice, vol.19, issue.9, pp.1239-1283, 2010. ,
DOI : 10.1111/j.1525-139X.2006.00218.x
Effect of Dipyridamole plus Aspirin on Hemodialysis Graft Patency, New England Journal of Medicine, vol.360, issue.21, pp.2191-201, 2009. ,
DOI : 10.1056/NEJMoa0805840
Clopidogrel Diminishes Hemodialysis Access Graft Thrombosis, Nephron Clinical Practice, vol.249, issue.3-4, pp.128-160, 2006. ,
DOI : 10.1016/S0140-6736(96)09457-3
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis, JAMA, vol.299, issue.18, pp.2164-71, 2008. ,
DOI : 10.1001/jama.299.18.2164
Randomized Controlled Trial of Clopidogrel plus Aspirin to Prevent Hemodialysis Access Graft Thrombosis, Journal of the American Society of Nephrology, vol.14, issue.9, pp.2313-2334, 2003. ,
DOI : 10.1097/01.ASN.0000081661.10246.33
Review: Does Warfarin Safely Prevent Clotting of Hemodialysis Catheters?, Seminars in Dialysis, vol.4, issue.Suppl. 1, pp.71-78, 2008. ,
DOI : 10.1111/hdi.2000.4.1.37
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheter (TCC) thrombosis, The Journal of Vascular Access, vol.203, issue.1, pp.118-140, 2006. ,
DOI : 10.1148/radiology.203.2.9114110
Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease, Journal of the American Society of Nephrology, vol.20, issue.4, pp.705-716, 2009. ,
DOI : 10.1681/ASN.2007111207
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest, vol.138, issue.5, pp.1093-100, 2010. ,
DOI : 10.1378/chest.10-0134
Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation, Circulation, vol.126, issue.7, pp.860-865, 2012. ,
DOI : 10.1161/CIRCULATIONAHA.111.060061
Prevalence of Atrial Fibrillation and Associated Factors in a Population of Long-Term Hemodialysis Patients, American Journal of Kidney Diseases, vol.46, issue.5, pp.897-902, 2005. ,
DOI : 10.1053/j.ajkd.2005.07.044
Stroke and Its Prevention in Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.2, issue.6, pp.1343-51, 2007. ,
DOI : 10.2215/CJN.04341206
Ischaemic stroke in incident dialysis patients, Nephrology Dialysis Transplantation, vol.31, issue.9, pp.3343-3351, 2010. ,
DOI : 10.1161/01.STR.31.9.2080
Antiplatelet Medications in Hemodialysis Patients: A Systematic Review of Bleeding Rates, Clinical Journal of the American Society of Nephrology, vol.4, issue.8 ,
DOI : 10.2215/CJN.00810209
Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients, Kidney International, vol.64, issue.4, pp.1455-61, 2003. ,
DOI : 10.1046/j.1523-1755.2003.00225.x
URL : https://doi.org/10.1046/j.1523-1755.2003.00225.x
Major Bleeding in Hemodialysis Patients, Clinical Journal of the American Society of Nephrology, vol.3, issue.1, pp.105-115, 2008. ,
DOI : 10.2215/CJN.01810407
URL : http://cjasn.asnjournals.org/content/3/1/105.full.pdf
Coumarins and survival in incident dialysis patients, Nephrology Dialysis Transplantation, vol.140, issue.6, pp.332-339, 2012. ,
DOI : 10.1067/mhj.2000.111111
URL : https://academic.oup.com/ndt/article-pdf/27/1/332/6908313/gfr341.pdf
Hemodialysis vascular access morbidity, J Am Soc Nephrol, vol.7, pp.523-558, 1996. ,
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial, American Heart Journal, vol.155, issue.4, pp.687-93, 2008. ,
DOI : 10.1016/j.ahj.2007.10.046
Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect?, Kidney International, vol.65, issue.3, pp.1017-1042, 2004. ,
DOI : 10.1111/j.1523-1755.2004.00473.x
Platelets: Physiology and Biochemistry, Seminars in Thrombosis and Hemostasis, vol.31, issue.04, pp.381-92, 2005. ,
DOI : 10.1055/s-2005-916671
URL : http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2005-916671.pdf
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular risk, American Journal of Kidney Diseases, vol.40, issue.2, pp.315-337, 2002. ,
DOI : 10.1053/ajkd.2002.34510
Essentials of anticoagulation in hemodialysis, Hemodialysis International, vol.38, issue.7, pp.178-89, 2007. ,
DOI : 10.1046/j.1523-1755.1999.00671.x
Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis, JAMA, vol.302, issue.16, pp.1782-1791, 1488. ,
DOI : 10.1001/jama.2009.1488
Cardiovascular Mortality in the General Population Versus Dialysis: A Glass Half Full or Empty?, American Journal of Kidney Diseases, vol.58, issue.1, pp.4-6, 2011. ,
DOI : 10.1053/j.ajkd.2011.04.004
Cardiovascular disease in patients with chronic kidney disease, Vasc Health Risk Manag, vol.5, pp.713-735, 2009. ,
Cardiovascular risk factors in patients with chronic kidney disease, Nature Reviews Cardiology, vol.44, issue.9, pp.580-589, 2009. ,
DOI : 10.7326/0003-4819-138-2-200301210-00010
The ABCs of Cardioprotection in Dialysis Patients: A Systematic Review, American Journal of Kidney Diseases, vol.53, issue.3, pp.457-66, 2009. ,
DOI : 10.1053/j.ajkd.2008.07.037
Outcomes Associated With Combined Antiplatelet and Anticoagulant Therapy, Chest, vol.133, issue.4, pp.948-54, 2008. ,
DOI : 10.1378/chest.07-2627
Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients, Journal of the American Society of Nephrology, vol.20, issue.4, pp.872-81, 2009. ,
DOI : 10.1681/ASN.2008080824
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663838/pdf
Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation, Journal of the American Society of Nephrology, vol.20, issue.10, pp.2223-2256, 2009. ,
DOI : 10.1681/ASN.2009030319